S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Connamara Technologies Adds Bilateral Matching to EP3 Platform

Austin-based Connamara Technologies has upgraded its EP3 exchange platform to support bilateral matching, allowing operators to launch markets governed by direct counterparty agreements rather than central clearing. This shift enables firms to navigate complex regulatory landscapes while diversifying the types of assets and trading structures they can host.

Connamara Technologies Adds Bilateral Matching to EP3 Platform
Photo: Bio & News

The new matching algorithm validates contractual terms and notional limits in real-time, ensuring orders only execute if they satisfy specific bilateral conditions. This approach marks a departure from traditional centrally cleared models, providing exchange operators with greater flexibility in how they structure participant interactions.

Key technical updates include dedicated API endpoints for managing bilateral agreements, participant-specific market data feeds, and instrument-level configuration for matching logic. By allowing different instruments to operate under distinct rules within the same exchange, the platform accommodates a broader range of financial products. According to CEO Jim Downs, this modularity is essential for operators looking to capture new participants and adapt to shifting market demands. The update further automates limit adjustments and trade clearing, reducing the overhead typically associated with complex, multi-party trading environments.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!